An Act relative to patient assessment and notification prior to prescribing certain medications
This bill mandates that healthcare providers assess patients and notify them before prescribing certain medications. It aims to ensure better patient awareness and safety regarding medications.
Do you support it?
Want to know if it passes?
We'll email you when H2414 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on H2414.
You're tracking H2414
We'll email you the moment it moves.
H2414 — An Act relative to patient assessment and notification prior to prescribing certain medications
No card. One bill, free forever — alerts when it moves.
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
In plain language
The bill requires patient assessment before prescribing specific medications.
This bill mandates that healthcare providers assess patients and notify them before prescribing certain medications. It aims to ensure better patient awareness and safety regarding medications.
What this means for you
- Healthcare: Healthcare providers will need to implement assessment and notification processes for specific medications.
Summary
An Act relative to patient assessment and notification prior to prescribing certain medications
Bill Text
- Full text Current
AI-generated reading aid from the bill's amendatory text — verify against the official bill.
The bill adds definitions for benzodiazepines and non-benzodiazepine hypnotics, establishes new consent requirements for prescribing these medications, and revises existing opioid prescription protocols to enhance patient safety and informed consent.
-
Chapter 94C
“Benzodiazepine”, any substance or drug that: (i) contains a benzene ring fused to a 7 member diazepine ring; (ii) results in the depression of the central nervous system; (iii) is primarily intended to treat insomnia, convulsions and anxiety; and (iv) is used for muscle relaxation and pre-operation treatment, including alprazolam, clonazepam, diazepam, lorazepam and temazepam.
This adds a definition for benzodiazepines to the laws governing controlled substances.
-
Chapter 94C
“Non-benzodiazepine hypnotic”, any substance or drug that produces effects similar to that of a benzodiazepine and is primarily intended to treat insomnia, including zaleplon, zopiclone and zolpidem.
This adds a definition for non-benzodiazepine hypnotics to the laws governing controlled substances.
-
Section 18A
subsection (a)→ (a) Prior to prescribing an extended-release long-acting opioid in a non-abuse deterrent form for outpatient use for the first time, a practitioner registered under section 7, not including veterinarians, shall conduct a review with a patient, and if the patient is a minor, the patient’s parent or legal guardian...This establishes new review and consent requirements for practitioners before prescribing extended-release long-acting opioids.
-
Chapter 94C
Section 18A1/2. Prior to prescribing a benzodiazepine or a non-benzodiazepine hypnotic for the first time, a practitioner registered under section 7, not including veterinarians, shall conduct a review with a patient, and if the patient is a minor, the patient’s parent or legal guardian...
This introduces new consent and review requirements for prescribing benzodiazepines and non-benzodiazepine hypnotics.
-
Section 18C
section 18C→ Section 18C. Prior to prescribing an opioid contained in Schedule II or any other opioid pain reliever for the first time, a practitioner registered under section 7, not including veterinarians, shall conduct a review with a patient, and if the patient is a minor, the patient’s parent or legal guardian...This amendments revise the existing protocol for prescribing Schedule II opioids to include additional review requirements and consent.
Sponsors
- Carole A. Fiola · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 203 not signed on
Sponsors (1)
- Carole A. Fiola Democrat
Co-sponsors (0)
None.
Not signed on (203)
203 members have not signed on to this bill.
Show all 203 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does H2414 do?
- An Act relative to patient assessment and notification prior to prescribing certain medications
- Who sponsors H2414?
- H2414 is sponsored by Carole A. Fiola (Democrat).
- What is the current status of H2414?
- This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track H2414?
- Track H2414 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on H2414
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of H2414
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →